Ghrelin and the differential regulation of des-acyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT)

Clinical Endocrinology

Volumn 70, Issue 3, 2009, Pages 383-389

  Kos, K ^b   Harte, A L ^b   O'Hare, P J ^b   Kumar, S ^b   McTernan, P G ^a,b  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; LEPTIN; LIPOPROTEIN LIPASE;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; ELECTIVE SURGERY; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ADIPOCYTES; ADULT; ARGININE; BODY MASS INDEX; CELLS, CULTURED; FEMALE; GHRELIN; HUMANS; LEPTIN; LIPOGENESIS; LIPOLYSIS; LIPOPROTEIN LIPASE; MIDDLE AGED; RECEPTORS, NEUROPEPTIDE Y; SUBCUTANEOUS FAT;

EID: 60449098658     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03321.x     Document Type: Article

References (35)

1. Tschop, M., Smiley, D.L. Heiman, M.L. (2000) Ghrelin induces adiposity in rodents. Nature, 407, 908 913.
2. Tschop, M., Weyer, C., Tataranni, P.A. et al. (2000) Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707 709.
3. Gnanapavan, S., Kola, B., Bustin, S.A. et al. (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism, 87, 2988.
4. Kojima, M., Hosoda, H., Date, Y. et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656 660.
5. Kojima, M. Kangawa, K. (2005) Ghrelin: structure and function. Physiological Reviews, 85, 495 522.
6. Ghigo, E., Broglio, F., Arvat, E. et al. (2005) Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clinical Endocrinology, 62, 1 17.
7. Dixit, V.D., Schaffer, E.M., Pyle, R.S. et al. (2004) Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. Journal of Clinical Investigation, 114, 57 66.
8. Hosoda, H., Kojima, M., Matsuo, H. et al. (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochemical and Biophysical Research Communications, 279, 909 913.
9. Thompson, N.M., Gill, D.A., Davies, R. et al. (2004) Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology, 145, 234 242.
10. van der Lely, A.J., Tschöp, M., Heiman, M.L. et al. (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews, 25, 426 457.
11. Theander-Carrillo, C., Wiedmer, P., Cettour-Rose, P. et al. (2006) Ghrelin action in the brain controls adipocyte metabolism. Journal of Clinical Investigation, 116, 1983 1993.
12. Morimoto, C., Tsujita, T. Okuda, H. (1998) Antilipolytic actions of insulin on basal and hormone-induced lipolysis in rat adipocytes. Journal of Lipid Research, 39, 957 962.
13. Muccioli, G., Pons, N., Ghe, C. et al. (2004) and. Ghigo, E Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. European Journal of Pharmacology, 498, 27 35.
14. Asakawa, A., Inui, A., Kaga, T. et al. (2003) Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut, 52, 947 952.
15. Tebbe, J.J., Tebbe, C.G., Mronga, S. et al. (2005) Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats. BMC Gastroenterology, 5, 5.
16. Kos, K., Harte, A.L., James, S. et al. (2007) Secretion of Neuropeptide Y (NPY) in human adipose tissue and its role in maintenance of adiposity. American Journal of Physiology. Endocrinology and Metabolism, 293, 1335 1340.
17. Harte, A.L., McTernan, P.G., McTernan, C.L. et al. (2003) Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes. Diabetes, Obesity and Metabolism, 5, 302 310.
18. Entzeroth, M., Braunger, H., Eberlein, W. et al. (1995) Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226. European Journal of Pharmacology, 278, 239 242.
19. McTernan, P.G., Harte, A.L., Anderson, L.A. et al. (2002) Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes, 51, 1493 1498.
20. Purnell, J.Q., Weigle, D.S., Breen, P. et al. (2003) Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. Journal of Clinical Endocrinology and Metabolism, 88, 5747 5752.
21. Serradeil-Le Gal, C., Lafontan, M., Raufaste, D. et al. (2000) Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes. FEBS Letters, 475, 150 156.
22. Yang, Y.S., Song, H.D., Li, R.Y. et al. (2003) The gene expression profiling of human visceral adipose tissue and its secretary functions. Biochemical and Biophysical Research Communications, 300, 839 846.
23. Banks, W.A., Tschöp, M., Robinson, S.M. et al. (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. The Journal of Pharmacology and Experimental Therapeutics, 302, 822 827.
24. Tritos, N.A., Kokkinos, A., Lampadariou, E. et al. (2003) Cerebrospinal fluid ghrelin is negatively associated with body mass index. Journal of Clinical Endocrinology and Metabolism, 88, 2943 2946.
25. Cummings, D.E., Purnell, J.Q., Frayo, R.S. et al. (2001) Preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes, 50, 1714 1719.
26. English, P.J., Ghatei, M.A., Malik, I.A. et al. (2002) Food fails to suppress ghrelin levels in obese humans. Journal of Clinical Endocrinology and Metabolism, 87, 2984 2987.
27. Choi, K., Roh, S.G., Hon, Y.H. et al. (2003) The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology, 144, 754 759.
28. Broglio, F., Gottero, C., Prodam, F. et al. (2004) Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism, 89, 3062 3065.
29. Patel, A.D., Stanley, S.A., Murphy, K.G. et al. (2006) Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regulatory Peptides, 134, 17 22.
30. Shintani, M., Ogawa, Y., Ebihara, K. et al. (2001) Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes, 50, 227 232.
31. Sylte, I., Andrianjara, C.R., Calvet, A. et al. (1999) Molecular dynamics of NPY Y1 receptor activation. Bioorganic and Medicinal Chemistry, 7, 2737 2748.
32. Labelle, M., Boulanger, Y., Fournier, A. et al. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides, 18, 801 808.
33. Ishihara, A., Kanatani, A., Okad, a, M. et al. (2002) Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist. British Journal of Pharmacology, 136, 341 346.
34. Wang, M.Y., Orci, L., Ravazzola, M. et al. (2005) Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proceedings of the National Academy of Sciences USA, 102, 18011 18016.
35. Chan, J.L., Bullen, J., Lee, J.H. et al. (2004) Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 89, 335 343.